Biodegradable nanoparticles for drug delivery and targeting

Aprahamian, 1987, Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Biol Cell, 61, 69, 10.1111/j.1768-322X.1987.tb00571.x

Soppimath, 2001, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release, 70, 1, 10.1016/S0168-3659(00)00339-4

Florence, 1997, The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual, Pharm. Res., 14, 259, 10.1023/A:1012029517394

Florence, 2001, Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas, Adv. Drug Deliv. Rev., 50, S69, 10.1016/S0169-409X(01)00184-3

Torche, 2000, Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer’s patch segment, Int. J. Pharm., 201, 15, 10.1016/S0378-5173(00)00364-1

Lemoine, 1998, Polymeric nanoparticles as delivery system for influenza virus glycoproteins, J. Control. Release, 54, 15, 10.1016/S0168-3659(97)00241-1

Blanco, 1997, Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres, Eur. J. Pharm. Biopharm., 43, 287, 10.1016/S0939-6411(97)00056-8

Suh, 1998, Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres, J. Biomed. Mater. Res., 42, 331, 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L

Song, 1997, Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery, J. Control. Release, 43, 197, 10.1016/S0168-3659(96)01484-8

Cheng, 1998, A poly(d,l-lactide-co-glycolide) microsphere depot system for delivery of haloperidol, J. Control. Release, 55, 203, 10.1016/S0168-3659(98)00056-X

Feng, 2001, Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers, J. Control. Release, 71, 53, 10.1016/S0168-3659(00)00364-3

Vila, 2002, Design of biodegradable particles for protein delivery, J. Control. Release, 78, 15, 10.1016/S0168-3659(01)00486-2

Rafati, 1997, Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics, J. Control. Release, 43, 89, 10.1016/S0168-3659(96)01475-7

Li, 2001, PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats, J. Control. Release, 71, 203, 10.1016/S0168-3659(01)00218-8

Carino, 2000, Nanosphere based oral insulin delivery, J Control Release, 65, 261, 10.1016/S0168-3659(99)00247-3

Kwon, 2001, Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method, Colloids Surf, 182, 123, 10.1016/S0927-7757(00)00825-6

Takeuchi, 2001, Mucoadhesive nanoparticulate systems for peptide drug delivery, Adv Drug Deliv, 47, 39, 10.1016/S0169-409X(00)00120-4

Govender, 1999, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J Control Release, 57, 171, 10.1016/S0168-3659(98)00116-3

Murakami, 1999, Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int J Pharm, 187, 143, 10.1016/S0378-5173(99)00187-8

Verger, 1998, Preparation and characterization of nanoparticles containing an antihypertensive agent, Eur J Pharm Biopharm, 46, 137, 10.1016/S0939-6411(98)00015-0

Leroux, 1996, Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery, J Control Release, 39, 339, 10.1016/0168-3659(95)00164-6

Sakuma, 2001, Design of nanoparticles composed of graft copolymers for oral peptide delivery, Adv Drug Deliv, 47, 21, 10.1016/S0169-409X(00)00119-8

Behan, 2001, Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation, Biomaterials, 22, 1335, 10.1016/S0142-9612(00)00286-6

Janes, 2001, Polysaccharide colloidal particles as delivery systems for macromolecules, Adv Drug Deliv, 47, 83, 10.1016/S0169-409X(00)00123-X

Hu Y. et al. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, in press.

Fontana, 1998, Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles, Biomaterials, 19, 1009, 10.1016/S0142-9612(97)00246-9

Chacon, 1999, Stability and freeze-drying of cyclosporine loaded poly(d,l-lactide-glycolide) carriers, Eur J Pharm Sci, 8, 99, 10.1016/S0928-0987(98)00066-9

Saez, 2000, Freeze-drying of polycarolactone and poly(d,l-lactic-glycolic) nanoparticles induces minor particle size changes affecting the oral pharmacokinetics of loaded drugs, Eur J Pharm Biopharm, 50, 379, 10.1016/S0939-6411(00)00125-9

Kreuter, 2001, Nanoparticulate systems for brain delivery of drugs, Adv Drug Deliv, 47, 65, 10.1016/S0169-409X(00)00122-8

Arias, 2001, Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles, J Control Release, 77, 309, 10.1016/S0168-3659(01)00519-3

Fontana, 2001, Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake, Biomaterials, 22, 2857, 10.1016/S0142-9612(01)00030-8

Jung, 2000, Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres, J Control Release, 67, 157, 10.1016/S0168-3659(00)00201-7

Yoo, 2000, In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates, J Control Release, 68, 419, 10.1016/S0168-3659(00)00280-7

Nicoli, 2001, Design of triptorelin loaded nanospheres for transdermal iontophoretic administration, Int J Pharm, 214, 31, 10.1016/S0378-5173(00)00632-3

Muller, 2001, Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future, Adv Drug Deliv, 47, 3, 10.1016/S0169-409X(00)00118-6

Gref, 2000, ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids Surf B, 18, 301, 10.1016/S0927-7765(99)00156-3

Tobio, 2000, The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration, Colloids Surf B, 18, 315, 10.1016/S0927-7765(99)00157-5

Peracchia, 1999, Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting, J Control Release, 60, 121, 10.1016/S0168-3659(99)00063-2

Panagi, 2001, Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles, Int J Pharm, 221, 143, 10.1016/S0378-5173(01)00676-7

Redhead, 2001, Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation, J Control Release, 70, 353, 10.1016/S0168-3659(00)00367-9

Fishbein, 2000, Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis, J Control Release, 65, 221, 10.1016/S0168-3659(99)00244-8

Song, 1998, Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model, J Control Release, 54, 201, 10.1016/S0168-3659(98)00016-9

Nishioka, 2001, Lymphatic targeting with nanoparticulate system, Adv Drug Deliv, 47, 55, 10.1016/S0169-409X(00)00121-6

Lambert, 2001, Nanoparticulate systems for the delivery of antisense oligonucleotides, Adv Drug Deliv, 47, 99, 10.1016/S0169-409X(00)00116-2

Perez, 2001, Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA, J Control Release, 75, 211, 10.1016/S0168-3659(01)00397-2

Illum, 2001, Chitosan as a novel nasal delivery system for vaccines, Adv Drug Deliv Rev, 51, 81, 10.1016/S0169-409X(01)00171-5

DeCampos, 2001, Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A, Int J Pharm, 224, 159, 10.1016/S0378-5173(01)00760-8

Matsumoto, 1999, Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evolution in vitro, Int J Pharm, 185, 93, 10.1016/S0378-5173(99)00153-2

Avgoustakis, 2002, PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vivo drug release and in vivo drug residence in blood properties, J Control Release, 79, 123, 10.1016/S0168-3659(01)00530-2